Results 71 to 80 of about 195,293 (269)

Rheopheresis in vascular diseases [PDF]

open access: yes, 2018
K
Baráth, Sándor   +7 more
core   +1 more source

Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein(a) Levels in Patients With Acute Coronary Syndrome

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 1, Page 64-72, July 1, 2025.
ABSTRACT Background Lipoprotein(a) [Lp(a)] is associated with increased cardiovascular risk, but its influence on plaque characteristics at optical coherence tomography (OCT) evaluation is not fully understood. Aims This study seeks to explore the impact of Lp(a) levels on plaque morphology as assessed by OCT in a very high‐risk subset of patients ...
Francesca Maria Di Muro   +13 more
wiley   +1 more source

The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.

open access: yesJournal of Nutritional Science and Vitaminology, 2015
Lipid apheresis (extracorporeal lipoprotein elimination) is administered to patients with familial hypercholesterolemia who fail to respond to standard therapy.
D. Solichová   +9 more
semanticscholar   +1 more source

Extracorporeal LDL-Cholesterol Elimination in the Treatment of Severe Familial Hypercholesterolemia

open access: yesActa Medica, 2003
The extracorporeal elimination of LDL-cholesterol could be performed using the classic non-selective centrifuge or membrane plasmapheresis. The modern methods are more selective and effective.
Milan Bláha
doaj   +1 more source

Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide [PDF]

open access: yes, 2015
Homozygous familial hypercholesterolaemia (HoFH) is a rare genetic disease characterised by markedly elevated plasma levels of low-density lipoprotein-cholesterol (LDL-C).
Alonso, R.   +2 more
core   +1 more source

Lipid-Apheresis Improves Microcirculation of the Upper Limbs [PDF]

open access: yes, 2012
Mit Lipid-Apherese (LA) ist es möglich die Mikrozirkulation zu verbessern. Wir haben die Mikrozirkulation der oberen Extremitäten von 22 Patienten vor und nach wöchentlicher LA untersucht.
Rossenbach, Jannik
core  

HEART UK Consensus Statement on Lipoprotein(a) - a call to action [PDF]

open access: yes, 2019
Lipoprotein(a), Lp(a), is a modified atherogenic low-density lipoprotein particle that contains apolipoprotein(a). Its levels are highly heritable and variable in the population. This consensus statement by HEART UK is based on the evidence that Lp(a) is
Byrne, Chris D   +16 more
core   +3 more sources

Beyond lipids: Systemic effects of lipoprotein apheresis

open access: yes
Transfusion, EarlyView.
Menatalla Nadim, Yamac Akgun
wiley   +1 more source

Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes

open access: yesJACC: Case Reports, 2019
This case report describes a 50-year-old-woman from Southeast Asia with extensive atherosclerotic cardiovascular disease, found to have homozygous familial hypercholesterolemia caused by variants of uncertain significance in both the APOB and LDLR genes.
Robert Derenbecker, MD   +7 more
doaj   +1 more source

Three patients with homozygous familial hypercholesterolemia: Genomic sequencing and kindred analysis. [PDF]

open access: yes, 2019
BackgroundHomozygous Familial Hypercholesterolemia (HoFH) is an inherited recessive condition associated with extremely high levels of low-density lipoprotein (LDL) cholesterol in affected individuals.
Balamir, Melek   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy